Joel S. Bedford

Joel S. Bedford

Fondatore presso KromaTid, Inc.

Health Technology

Provenienza dei contatti di primo grado di Joel S. Bedford

EntitàTipo di entitàSettore Industriale
14
Holding Company Pharmaceuticals: Major 14

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Joel S. Bedford tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
ABBOTT LABORATORIES Medical Specialties

Terry Opgenorth

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Nicholas A. Saccomano

Corporate Officer/Principal

ARRAY TECHNOLOGIES, INC. Pharmaceuticals: Major

Nicholas A. Saccomano

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Nathan Wood

Director/Board Member

Medical/Nursing Services

James E. Chomas

Chief Executive Officer

Biotechnology

Nicholas A. Saccomano

Chief Executive Officer

Agricultural Commodities/Milling

Terry Opgenorth

Founder

NOVARTIS AG Pharmaceuticals: Major

Vic Myer

Director/Board Member

Industrial Machinery

James E. Chomas

Corporate Officer/Principal

The Trustees of Columbia University in The City of New York College/University

Nicholas A. Saccomano

Doctorate Degree

College/University

James E. Chomas

Undergraduate Degree

Investment Managers

Vic Myer

Consultant / Advisor

Calvin University College/University

Terry Opgenorth

Undergraduate Degree

Kalamazoo College College/University

Gretchen Pratt

Undergraduate Degree

Yale University College/University

Vic Myer

Doctorate Degree

College/University

Vic Myer

Undergraduate Degree

North Carolina State University College/University

Christopher Tompkins

Doctorate Degree

Oregon State University College/University

Nathan Wood

Undergraduate Degree

University of Illinois College/University

Terry Opgenorth

Doctorate Degree

Packaged Software

David Brunel

Chairman

Medical Specialties

David Brunel

Nicholas A. Saccomano

Founder

Chief Tech/Sci/R&D Officer

The State University of New York College/University

Nicholas A. Saccomano

Undergraduate Degree

Pharmaceuticals: Major

Nicholas A. Saccomano

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Terry Opgenorth

Director/Board Member

Miscellaneous Commercial Services

Virginia Orndorff

James E. Chomas

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Nathan Wood

Corporate Officer/Principal

Services to the Health Industry

James E. Chomas

Director/Board Member

Miscellaneous Commercial Services

Terry Opgenorth

Director/Board Member

Biotechnology

Vic Myer

Corporate Officer/Principal

Investment Managers

Nicholas A. Saccomano

Private Equity Investor

Pharmaceuticals: Major

James E. Chomas

Chief Executive Officer

Medical/Nursing Services

Terry Opgenorth

Director/Board Member

Colorado Institute

Terry Opgenorth

Director/Board Member

Medical/Nursing Services

Virginia Orndorff

Terry Opgenorth

Chief Executive Officer

Director/Board Member

EDITAS MEDICINE, INC. Biotechnology

Vic Myer

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Generic

Terry Opgenorth

Chief Executive Officer

Pharmaceuticals: Major

Terry Opgenorth

Director/Board Member

Biotechnology

Jack Ball

Director/Board Member

Pharmaceuticals: Major

F. Andrew Ray

Director/Board Member

ELANCO ANIMAL HEALTH INCORPORATED Biotechnology

Terry Opgenorth

Corporate Officer/Principal

Standards Coordinating Body

Vic Myer

Director/Board Member

Pharmaceuticals: Major

Vic Myer

President

Financial Conglomerates

Terry Opgenorth

Director/Board Member

Biotechnology

Terry Opgenorth

Chairman

Biotechnology

Nicholas A. Saccomano

Director/Board Member

Biotechnology

Jack Ball

Nathan Wood

Director/Board Member

President

Statistiche

Distribuzione geografica

Stati Uniti 50
Svizzera 2

Settori

Health Technology 22
Consumer Services 11
Commercial Services 7
Health Services 5
Finance 4

Posizioni

Director/Board Member 47
Corporate Officer/Principal 18
Chief Executive Officer 15
Founder 11
President 11
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA